Bioventures Fund
One of 10,000+ projects Taiyo tracks in South Africa.
Source: International Finance Corporation (IFC)
The primary goal of Bioventures is to provide term risk capital to early stage bioventure enterprises in South Africa that have defined market and export strategies, proprietary or exclusive technologies, and skillful management teams. The targeted biotechnology sectors are:Pharmaceuticals and fine chemicals based on natural, animal, fungal or microbial products;Healthcare technologies including
- Status
- Closed
- Sector
- Raw Materials, Manufacturing (Industrial), Hospital, Government, Waste Processing and Treatment
- Location
- South Africa
- Updated
- 22 Jul 2026
- Source
- International Finance Corporation (IFC)
ConstructChat
Ask ConstructChat about Bioventures Fund
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The primary goal of Bioventures is to provide term risk capital to early stage bioventure enterprises in South Africa that have defined market and export strategies, proprietary or exclusive technologies, and skillful management teams. The targeted biotechnology sectors are:Pharmaceuticals and fine chemicals based on natural, animal, fungal or microbial products;Healthcare technologies including vaccine development, medical devices, diagnostics;Genomics including drug discovery based on genomic information, bioinformatics, tool makers and service providers to the genomic industry;Agriculture, floriculture and mariculture that are innovative technologies used to improve current agricultural practices. Individual farming activities will not be invested in;Nutraceuticals which is production of enhanced, beneficial foodstuffs often using natural plant products; and Biomaterials and bioprocessing including industrial biotechnology for the production of proteins, waste bio-remediation, development of bio-fuels, and others.By investing in Bioventures, IFC will be providing long-term funding to companies which have difficulty accessing such funding through available sources. It will also signal to other providers of funding to consider investing in biotechnology and other sectors which are traditionally considered risky. Success of the Fund would have a demonstration effect to domestic institutional investors and may result in greater allocation of funds to venture capital. Bioventures, the first biotechnology venture capital fund in South Africa, will be a pioneer in promoting the development of biotechnology expertise in South Africa and will therefore play a role in creating jobs and attracting skills in the sector as well as help reduce the brain drain of skilled manpower out of South Africa. The investee firms would develop stronger management teams and business plans and both the Fund and IFC could eventually contribute to the internationalization of successful ventures. Biotechnology products are considered as easily exportable and therefore could generate hard currency to the national economy. It is expected that IFC would nominate a Director to the Board of Trustees or Governing Board, and thereby contribute to the corporate governance of the Fund. |
Original sector | BC - Private Equity/Venture Cap Fund - Sector |
Location
Country | South Africa |
Source
Source | International Finance Corporation (IFC) |
URL |
More Details
Record type | Project |
Sector | Raw Materials, Manufacturing (Industrial), Hospital, Government, Waste Processing and Treatment |
Article published date | 2025-08-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
